BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11377651)

  • 41. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma.
    Mellon EA; Hoffe SE; Springett GM; Frakes JM; Strom TJ; Hodul PJ; Malafa MP; Chuong MD; Shridhar R
    Acta Oncol; 2015 Jul; 54(7):979-85. PubMed ID: 25734581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intraoperative radiotherapy in the combined-modality management of pancreatic cancer.
    Schuricht AL; Spitz F; Barbot D; Rosato F
    Am Surg; 1998 Nov; 64(11):1043-9. PubMed ID: 9798766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumour cryoablation combined with palliative bypass surgery in the treatment of unresectable pancreatic cancer: a retrospective study of 142 patients.
    Li J; Chen X; Yang H; Wang X; Yuan D; Zeng Y; Wen T; Yan L; Li B
    Postgrad Med J; 2011 Feb; 87(1024):89-95. PubMed ID: 21131612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.
    Labori KJ; Katz MH; Tzeng CW; Bjørnbeth BA; Cvancarova M; Edwin B; Kure EH; Eide TJ; Dueland S; Buanes T; Gladhaug IP
    Acta Oncol; 2016; 55(3):265-77. PubMed ID: 26213211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
    Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
    Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of chemoembolization in synchronous liver metastases from pancreatic endocrine tumours.
    Falconi M; Bassi C; Bonora A; Sartori N; Procacci C; Talamini G; Mansueto GC; Pederzoli P
    Dig Surg; 1999; 16(1):32-8. PubMed ID: 9949265
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A; Kies MS; Myers J; Clayman G; Hong WK
    Cancer; 2002 Jul; 95(2):322-30. PubMed ID: 12124833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [High-intensity focused ultrasound (HIFU) for tumor pain relief in inoperable pancreatic cancer : Evaluation with the pain sensation scale (SES)].
    Marinova M; Strunk HM; Rauch M; Henseler J; Clarens T; Brüx L; Dolscheid-Pommerich R; Conrad R; Cuhls H; Radbruch L; Schild HH; Mücke M
    Schmerz; 2017 Feb; 31(1):31-39. PubMed ID: 27402264
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extravascular use of drug-eluting beads: a promising approach in compartment-based tumor therapy.
    Binder S; Lewis AL; Löhr JM; Keese M
    World J Gastroenterol; 2013 Nov; 19(43):7586-93. PubMed ID: 24282349
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adjuvant S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma.
    Shinkawa H; Uenishi T; Takemura S; Sakata C; Urata Y; Nozawa A; Hamano G; Kinoshita M; Kubo S
    Hepatogastroenterology; 2015; 62(137):169-74. PubMed ID: 25911890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Borderline resectable pancreatic cancer: rationale for multidisciplinary treatment.
    Takahashi S; Kinoshita T; Konishi M; Gotohda N; Kato Y; Kinoshita T; Kobayashi T; Mitsunaga S; Nakachi K; Ikeda M
    J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):567-74. PubMed ID: 21331805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas.
    Sa Cunha A; Rault A; Laurent C; Adhoute X; Vendrely V; Béllannée G; Brunet R; Collet D; Masson B
    J Am Coll Surg; 2005 Sep; 201(3):359-65. PubMed ID: 16125068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of perioperative red blood cell transfusion on disease recurrence and survival after pancreaticoduodenectomy for ductal adenocarcinoma.
    Kneuertz PJ; Patel SH; Chu CK; Maithel SK; Sarmiento JM; Delman KA; Staley CA; Kooby DA
    Ann Surg Oncol; 2011 May; 18(5):1327-34. PubMed ID: 21369744
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neoadjuvant therapy versus upfront surgery for resected pancreatic adenocarcinoma: A nationwide propensity score matched analysis.
    de Geus SW; Eskander MF; Bliss LA; Kasumova GG; Ng SC; Callery MP; Tseng JF
    Surgery; 2017 Mar; 161(3):592-601. PubMed ID: 28341441
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic Factors for Pancreatic Cancer Patients Treated with Immune-cell Therapy.
    Makita K; Kamigaki T; Okada S; Matsuda E; Ibe H; Oguma E; Naitoh K; Takimoto R; Goto S
    Anticancer Res; 2018 Jul; 38(7):4353-4360. PubMed ID: 29970573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
    Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
    Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-Term Survival of Cellulose Sulphate-Encapsulated Cells and Metronomic Ifosfamide Control Tumour Growth in Pancreatic Cancer Models-A Prelude to Treating Solid Tumours Effectively in Pets and Humans.
    Salmons B; Gunzburg WH
    Life (Basel); 2023 Dec; 13(12):. PubMed ID: 38137959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of a human cell clone expressing cytochrome P450 for safe use in human somatic cell therapy.
    Günzburg WH; Karle P; Renz R; Salmons B; Renner M
    Ann N Y Acad Sci; 1999 Jun; 880():326-36. PubMed ID: 10415877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Encapsulated cells expressing a chemotherapeutic activating enzyme allow the targeting of subtoxic chemotherapy and are safe and efficacious: data from two clinical trials in pancreatic cancer.
    Löhr JM; Haas SL; Kröger JC; Friess HM; Höft R; Goretzki PE; Peschel C; Schweigert M; Salmons B; Gunzburg WH
    Pharmaceutics; 2014 Aug; 6(3):447-66. PubMed ID: 25116885
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of diseases of the central nervous system using encapsulated cells.
    Hottinger AF; Aebischer P
    Adv Tech Stand Neurosurg; 1999; 25():3-20. PubMed ID: 10370715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.